Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis

Figure 2 Specific and overall risk of bias in the six randomized controlled trials. A: Risk of bias summary: Review authors’ judgments about each risk of bias item for each included study; B: Risk of bias graph: Review authors’ judgments about each risk of bias item presented as percentages across all included studies.